{"@type":"Dataset","go_id":["https://identifiers.org/GO:0009406","https://identifiers.org/GO:0008152"],"go_kw":["virulence","metabolism"],"integmet_study":"MTBLS1167","mesh_chemical_id":["https://identifiers.org/mesh:C044809","https://identifiers.org/mesh:D013261","https://identifiers.org/mesh:D000666","https://identifiers.org/mesh:D002244","https://identifiers.org/mesh:D005978"],"mesh_chemical_pubtator_kw":["trypanothione","sterol","AmB","Amphotericin B","amphotericin B","carbon","glutathione"],"mesh_disease_id":["https://identifiers.org/mesh:D007239","https://identifiers.org/mesh:D007896"],"mesh_disease_pubtator_kw":["infections","Leishmania infection"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:5665","https://identifiers.org/taxonomy:38568"],"ncbi_taxonomy_pubtator_kw":["L. mexicana","Leishmania"],"source_id":"https://identifiers.org/metabolights:MTBLS1167","study_findings":"Metabolic changes may influence phenotypic profiles beyond drug resistance.","study_observation":"Metabolite abundance differences in AmB-resistant Leishmania lines.","study_summary":"Metabolomics study on AmB-resistant Leishmania phenotypic differences.","study_title_original":"Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites"}